Septerna

October is National Disability Employment Awareness Month, and this year’s theme, “Celebrating Value and Talent,” is one we see in action across #TeamSepterna every day. Talent shows up in many forms: in how someone designs an experiment, spots the problem no one else noticed, or makes a meeting work better for everyone in it. When people with disabilities can contribute fully, through flexible approaches, accessible tools, and a culture that asks rather than assumes, our science is stronger for it. As a company developing medicines for people living with chronic conditions, we know that what someone needs to thrive is rarely one-size-fits-all, in medicine or at work. #NDEAM #NDEAM2026 #DisabilityInclusion #Accessibility #LifeAtSepterna

In honor of National Hispanic Heritage Month, we celebrated alongside the Hispanic and Latino members of #TeamSepterna whose work moves our oral small molecule GPCR programs forward every day.      Science is stronger when the people doing it bring different histories, languages, and ways of seeing a problem to the bench and to the table. That range shapes the questions we ask and, ultimately, the people we’re able to serve.      #HispanicHeritageMonth #HHM2026 #LatinoHeritage #TeamSepterna #Biotechnology #PatientsInspireOurUrgency

Members of #TeamSepterna are in Phoenix through the weekend for the 2026 International HypoPARA Conference.    Septerna is a proud sponsor of this year’s meeting, hosted by the HypoPARAthyroidism Association. For three days, people living with hypoparathyroidism, caregivers, clinicians, researchers, gather to talk openly about what living with hypoparathyroidism looks like and what this community needs next.    Rajiv Patni M.D., our Chief Medical Officer, will present on Saturday, September 19 at 11:45 am.    Please stop by our table throughout the weekend.    #InternationalHypoPARAConference #hypoparathyroidism #hypopara #PatientsInspireOurUrgency #Endocrinology 

We’re looking forward to participating in two investor healthcare conferences in September. Members of our leadership team will take part in fireside chats at: Wells Fargo Healthcare Conference  📅 Tuesday, September 8 at 8 am EST | Boston Cantor Global Healthcare Conference 2026  📅 Thursday, September 10 at 11:30 am EST | New York Live webcasts will be available in the investors section of our website and archived for at least 30 days following each event. https://lnkd.in/gxnySKA5 #Biotech #GPCRs #DrugDiscovery #WellsFargoHealthcare #CantorHealthcare

We’re pleased to share that Rajiv Patni, M.D., has joined #TeamSepterna as Chief Medical Officer. Rajiv is a physician-scientist and biopharmaceutical executive with more than 25 years of experience leading clinical development, regulatory and medical affairs organizations. His experience will be invaluable as we advance our pipeline of oral small molecule drug candidates targeting GPCRs across endocrinology, immunology and inflammation, and metabolic diseases. Read the full announcement: https://lnkd.in/gnXSDngu #GPCR #DrugDiscovery #ClinicalDevelopment #Biotechnology

#TeamSepterna recently headed up to Mountain Terrace in Woodside for our Annual Summer Picnic, joined by families, friends, and a few very well-behaved dogs. Drug discovery and development depend on people who know each other well enough to challenge one another, ask for help, and keep going. Time away from the office and lab is core to how we build that. Thank you to everyone who joined us, and to the team who planned the perfect gathering. #LifeAtSepterna #CompanyCulture #Biotech 

Today, we reported our second quarter 2026 financial results alongside continued business progress across our portfolio of oral small molecule GPCR-targeted programs.    Read the full announcement: https://lnkd.in/gARPMAHx   #GPCR #Biotech #DrugDiscovery #PatientsInspireOurUrgency

We’re thrilled to welcome two exceptional leaders to #TeamSepterna!    Please join us in welcoming Kai Brown as Vice President, Commercial Strategy and Matt Paulson, Ph.D., MBA as Vice President, Program & Portfolio Management.    Kai will shape the commercial strategy for our GPCR-targeted pipeline, while Matt will lead program and portfolio management, helping advance our pipeline from discovery through clinical development. Both bring extensive expertise that will be instrumental as we advance our Native Complex Platform® and deliver GPCR-targeted therapies to patients with high unmet medical needs.    Interested in being a part of our strong, values-driven organization advancing cutting-edge science? Check out our open roles:  https://lnkd.in/ePmdQmsJ   #Biotech #DrugDiscovery #GPCR #NewHire #WelcomeToTheTeam #Leadership #LifeSciences #BiotechJobs

Advancing oral small molecule GPCR-targeted therapies takes an exceptional team. Today, we’re spotlighting two VPs helping move our pipeline forward.    Meet David McKenney, Ph.D., Vice President, Translational Biology. David leads our translational biology efforts, bridging preclinical research and clinical development across our GPCR-targeted pipeline.    Meet David K. Hong, MD, Vice President, Clinical Development. David helps advance our clinical development strategy across our GPCR-targeted pipeline.    Together, they reflect the depth of expertise across #TeamSepterna as we work to unlock the potential of GPCRs and deliver new medicines for patients in need.    Interested in joining #TeamSepterna? Explore our open roles: https://lnkd.in/ePmdQmsJ #Biotech #DrugDiscovery #GPCR #Leadership #LifeSciences #TeamSepterna #BiotechJobs 

Meet our 2026 summer intern class! 🌞    We’re thrilled to welcome Dylan Wong, Katie Hong, Manana Tsiskarishvili, Elena Liu, Chris La and Alexander Cocquyt to #TeamSepterna for a summer of hands-on science and more in South San Francisco.    They have been busy working alongside our talented team of drug hunters, GPCR experts, drug developers, and company builders, helping us advance our oral small molecule GPCR-targeted therapies for patients in need.    From synthesizing novel small molecules to developing cell-based assays, they’re already bringing fresh perspective, curiosity, and energy to our mission.     #TeamSepterna #Internship #STEM #DrugDiscovery #GPCR #LifeAtSepterna